Russell C. Petter - Concepedia

Author

Russell C. Petter

Also Known As

R Petter, R. C. PETTER, R. C. Petter, R. PETTER, R. Petter, R.C. Petter, Russell C Petter, Russell C. Petter, Russell Petter, Russell. Petter

123

Publications

5.6K

Citations

H-Index

Concepts

All Affiliations

Biogen (United States)University of Pittsburgh Clovis Oncology (United States)University of California, Los Angeles

About

Russell C. Petter is an author at Biogen (United States) specializing in medicine, pharmacology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	24	1.8K
2	Natural Sciences	14	14	869
3	Biochemistry	14	14	852
4	Engineering	8	8	972
5	Health Sciences	1	1	143

Russell C. Petter

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
Discovery of a Mutant-Selective Covalent Inhibitor of EGFR that Overcomes T790M-Mediated Resistance in NSCLC Annette O. Walter, Robert Tjin Tham Sjin, Henry J. Haringsma, Cancer Discovery	2013	622
Cooperative binding by aggregated mono-6-(alkylamino)-.beta.-cyclodextrins Russell C. Petter, Jeffrey S. Salek, Christopher T. Sikorski, Journal of the American Chemical Society EngineeringChemical AnalysisMedicineCyclodextrin ProductionAltmetric Attention Score	1990	465
Inhibition of Btk with CC-292 Provides Early Pharmacodynamic Assessment of Activity in Mice and Humans Erica N Evans, Richland Tester, Sharon Aslanian, Journal of Pharmacology and Experimental Therapeutics	2013	219
Catalytic hydrolysis of a phosphate triester by tetracoordinated zinc complexes Samuel H. Gellman, Russell C. Petter, Ronald Breslow Journal of the American Chemical Society Inorganic ChemistryChemical EngineeringBiological Inorganic ChemistryEngineeringChemical Analysis	1986	219
Targeted covalent drugs of the kinase family Juswinder Singh, Russell C. Petter, Arthur F. Kluge Current Opinion in Chemical Biology Medicinal ChemistryDrug TargetDrug TargetingMedicineReceptor Tyrosine Kinase	2010	175
Kinetics and Thermodynamics of Reversible Thiol Additions to Mono- and Diactivated Michael Acceptors: Implications for the Design of Drugs That Bind Covalently to Cysteines Elizabeth H. Krenske, Russell C. Petter, K. N. Houk The Journal of Organic Chemistry Thiol AdditionPharmaceutical ChemistrySmall MoleculesCysteine ThiolsMolecular Pharmacology	2016	149
N-Terminally PEGylated Human Interferon-β-1a with Improved Pharmacokinetic Properties and in Vivo Efficacy in a Melanoma Angiogenesis Model Darren P. Baker, Edward Yin-Shiang Lin, Ko‐Chung Lin, Bioconjugate Chemistry	2005	144
Free radicals in lipid bilayers: new probes of lipid radical dynamics Ned A. Porter, Russell C. Petter, William J. Brittain Journal of the American Chemical Society Lipid AnalysisProteinlipid InteractionMolecular SciencesBiochemistryDonut Icon	1984	143
Infrared spectrum of a single resin bead for real-time monitoring of solid-phase reactions Bing Yan, G. Kumaravel, H. V. Anjaria, The Journal of Organic Chemistry Real-time MonitoringEngineeringChemical AnalysisSingle Resin BeadAltmetric Attention Score	1995	118
Selective irreversible inhibition of a protease by targeting a noncatalytic cysteine Margit Hagel, Deqiang Niu, Thia St Martin, Nature Chemical Biology Selective Irreversible InhibitionBiochemistryProtein FoldingNatural SciencesMedicine	2010	92

Page 1